Alterity Therapeutics Ownership 2024 | Who Owns Alterity Therapeutics Now?
Institutional Ownership
0.00%
Institutional Holders
1.00
Alterity Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COPPELL ADVISORY SOLUTIONS LLC | - | - | - | -149 | -100.00% | - | Dec 31, 2023 |
Alterity Therapeutics's largest institutional shareholder is COPPELL ADVISORY SOLUTIONS LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COPPELL ADVISORY SOLUTIONS LLC | - | - | - | -149 | -100.00% | - | Dec 31, 2023 |
The largest Alterity Therapeutics shareholder by % of total assets is COPPELL ADVISORY SOLUTIONS LLC. The company owns 0.00 shares of Alterity Therapeutics (ATHE), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COPPELL ADVISORY SOLUTIONS LLC | - | - | - | -149 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Alterity Therapeutics's largest institutional buyer is COPPELL ADVISORY SOLUTIONS LLC. The company purchased -0.15K stocks of ATHE, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COPPELL ADVISORY SOLUTIONS LLC | - | - | - | -149 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Alterity Therapeutics's biggest institutional seller is COPPELL ADVISORY SOLUTIONS LLC. The company sold -0.15K shares of ATHE, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COPPELL ADVISORY SOLUTIONS LLC | - | - | - | -149 | -100.00% | - | Dec 31, 2023 |
Alterity Therapeutics's largest sold out institutional shareholder by shares sold is COPPELL ADVISORY SOLUTIONS LLC, sold -0.15K shares, valued at -, as of undefined.
Alterity Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 78,065 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 12,128 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 1,212 | - | - | Feb 29, 2024 |
Alterity Therapeutics's largest mutual fund holder by % of total assets is "TRUST FOR PROFESSIONAL MANAGERS", owning 78.06K shares, compromising 0.00% of its total assets.
Alterity Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Sep, 23 | 1 | - |
| 31 Dec, 22 | 11 | 57.14% |
| 30 Sep, 22 | 7 | 16.67% |
| 30 Jun, 22 | 6 | -40.00% |
| 31 Mar, 22 | 10 | 25.00% |
| 31 Dec, 21 | 8 | -27.27% |
| 30 Sep, 21 | 11 | 10.00% |
| 30 Jun, 21 | 10 | 11.11% |
| 31 Mar, 21 | 9 | 12.50% |
| 31 Dec, 20 | 8 | 14.29% |
| 30 Sep, 20 | 7 | -30.00% |
| 30 Jun, 20 | 10 | 100.00% |
| 31 Mar, 20 | 5 | -16.67% |
| 31 Dec, 19 | 6 | -14.29% |
| 30 Sep, 19 | 7 | -30.00% |
| 30 Jun, 19 | 10 | - |
As of 30 Sep 23, 1 institutions are holding Alterity Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Sep, 23 | 149 | - |
| 31 Dec, 22 | 661,303 | -2.16% |
| 30 Sep, 22 | 675,885 | -6.74% |
| 30 Jun, 22 | 724,694 | -7.09% |
| 31 Mar, 22 | 779,971 | 3.73% |
| 31 Dec, 21 | 751,929 | 17.93% |
| 30 Sep, 21 | 637,598 | -35.57% |
| 30 Jun, 21 | 989,609 | -1.38% |
| 31 Mar, 21 | 1,003,452 | -9.37% |
| 31 Dec, 20 | 1,107,233 | 76.76% |
| 30 Sep, 20 | 626,408 | 19.36% |
| 30 Jun, 20 | 524,818 | 74.42% |
| 31 Mar, 20 | 300,885 | -8.95% |
| 31 Dec, 19 | 330,448 | 27.82% |
| 30 Sep, 19 | 258,533 | -6.18% |
| 30 Jun, 19 | 275,556 | - |
Alterity Therapeutics (ATHE) has 149.00 shares outstanding as of 30 Sep 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Sep, 23 | - | - |
| 31 Dec, 22 | 1.65% | 58.05% |
| 30 Sep, 22 | 1.69% | 18.58% |
| 30 Jun, 22 | 3.01% | 28.66% |
| 31 Mar, 22 | 3.24% | 33.19% |
| 31 Dec, 21 | 3.13% | 61.49% |
| 30 Sep, 21 | 2.25% | 18.41% |
| 30 Jun, 21 | 3.50% | 27.80% |
| 31 Mar, 21 | 3.55% | 23.15% |
| 31 Dec, 20 | 3.92% | 22.20% |
| 30 Sep, 20 | 4.20% | 33.92% |
| 30 Jun, 20 | 3.52% | 86.46% |
| 31 Mar, 20 | 2.02% | 41.09% |
| 31 Dec, 19 | 2.22% | 34.91% |
| 30 Sep, 19 | 2.52% | 34.94% |
| 30 Jun, 19 | 2.69% | - |
As of 30 Sep 23, Alterity Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Sep, 23 | 1 | - |
| 31 Dec, 22 | 8 | 166.67% |
| 30 Sep, 22 | 3 | 50.00% |
| 30 Jun, 22 | 2 | -50.00% |
| 31 Mar, 22 | 4 | -20.00% |
| 31 Dec, 21 | 5 | 25.00% |
| 30 Sep, 21 | 4 | -20.00% |
| 30 Jun, 21 | 5 | 25.00% |
| 31 Mar, 21 | 4 | - |
| 31 Dec, 20 | 4 | - |
| 30 Sep, 20 | 4 | -42.86% |
| 30 Jun, 20 | 7 | 250.00% |
| 31 Mar, 20 | 2 | -50.00% |
| 31 Dec, 19 | 4 | 300.00% |
| 30 Sep, 19 | 1 | -90.00% |
| 30 Jun, 19 | 10 | - |
1 institutional shareholders have increased their position in ATHE stock as of 30 Sep 23 compared to 8 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Sep, 23 | - | - |
| 31 Dec, 22 | 1 | -50.00% |
| 30 Sep, 22 | 2 | 100.00% |
| 30 Jun, 22 | 1 | -66.67% |
| 31 Mar, 22 | 3 | 200.00% |
| 31 Dec, 21 | 1 | -66.67% |
| 30 Sep, 21 | 3 | 200.00% |
| 30 Jun, 21 | 1 | - |
| 31 Mar, 21 | 1 | - |
| 31 Dec, 20 | 1 | - |
| 30 Sep, 20 | - | - |
| 30 Jun, 20 | - | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | -100.00% |
| 30 Sep, 19 | 1 | - |
| 30 Jun, 19 | - | - |
- institutional shareholders have reduced their position in ATHE stock as of 30 Sep 23 compared to 1 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Sep, 23 | 1 | - | 149 | - | - | - | 1 | - | - | - |
| 31 Dec, 22 | 11 | 57.14% | 661,303 | -2.16% | 1.65% | 58.05% | 8 | 166.67% | 1 | -50.00% |
| 30 Sep, 22 | 7 | 16.67% | 675,885 | -6.74% | 1.69% | 18.58% | 3 | 50.00% | 2 | 100.00% |
| 30 Jun, 22 | 6 | -40.00% | 724,694 | -7.09% | 3.01% | 28.66% | 2 | -50.00% | 1 | -66.67% |
| 31 Mar, 22 | 10 | 25.00% | 779,971 | 3.73% | 3.24% | 33.19% | 4 | -20.00% | 3 | 200.00% |
| 31 Dec, 21 | 8 | -27.27% | 751,929 | 17.93% | 3.13% | 61.49% | 5 | 25.00% | 1 | -66.67% |
| 30 Sep, 21 | 11 | 10.00% | 637,598 | -35.57% | 2.25% | 18.41% | 4 | -20.00% | 3 | 200.00% |
| 30 Jun, 21 | 10 | 11.11% | 989,609 | -1.38% | 3.50% | 27.80% | 5 | 25.00% | 1 | - |
| 31 Mar, 21 | 9 | 12.50% | 1,003,452 | -9.37% | 3.55% | 23.15% | 4 | - | 1 | - |
| 31 Dec, 20 | 8 | 14.29% | 1,107,233 | 76.76% | 3.92% | 22.20% | 4 | - | 1 | - |
| 30 Sep, 20 | 7 | -30.00% | 626,408 | 19.36% | 4.20% | 33.92% | 4 | -42.86% | - | - |
| 30 Jun, 20 | 10 | 100.00% | 524,818 | 74.42% | 3.52% | 86.46% | 7 | 250.00% | - | - |
| 31 Mar, 20 | 5 | -16.67% | 300,885 | -8.95% | 2.02% | 41.09% | 2 | -50.00% | - | - |
| 31 Dec, 19 | 6 | -14.29% | 330,448 | 27.82% | 2.22% | 34.91% | 4 | 300.00% | - | -100.00% |
| 30 Sep, 19 | 7 | -30.00% | 258,533 | -6.18% | 2.52% | 34.94% | 1 | -90.00% | 1 | - |
| 30 Jun, 19 | 10 | - | 275,556 | - | 2.69% | - | 10 | - | - | - |
Alterity Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PMVP | PMV Pharmaceuticals, Inc. |
| MNPR | Monopar Therapeutics Inc. |
| ADIL | Adial Pharmaceuticals, Inc. |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| ADTX | Aditxt, Inc. |
| ARTL | Artelo Biosciences, Inc. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| SRZN | Surrozen, Inc. |
| RNAZ | TransCode Therapeutics, Inc. |
| VCNX | Vaccinex, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| HCWB | HCW Biologics Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| TARA | Protara Therapeutics, Inc. |
| ATXI | Avenue Therapeutics, Inc. |
| ABIO | ARCA biopharma, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
ATHE Ownership FAQ
Who Owns Alterity Therapeutics?
Alterity Therapeutics is owned by institutional shareholders (0%), insiders (0.00%), and public (0%). The largest institutional shareholder of Alterity Therapeutics is COPPELL ADVISORY SOLUTIONS LLC (0% of total shares) and the top mutual fund owner is TRUST FOR PROFESSIONAL MANAGERS (0.00% of total shares).
Who are the major institutional shareholders of Alterity Therapeutics?
Alterity Therapeutics's major institutional shareholders are COPPELL ADVISORY SOLUTIONS LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Alterity Therapeutics shareholders are there?
As of Sep 2023, there are 1 institutional shareholders of Alterity Therapeutics.
What percentage of Alterity Therapeutics is owned by COPPELL ADVISORY SOLUTIONS LLC?
COPPELL ADVISORY SOLUTIONS LLC owns 0 shares of Alterity Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).